A team of researchers led by scientists from Harvard Medical School and Boston Children’s Hospital has harnessed AI to design synthetic proteins that activate a key immune pathway. This is aimed at enabling large-scale generation of T cells.  The research…

How does a new carbon material promise to make proton therapy for cancer more precise and potent?